What are the ingredients, dosing guidelines, contraindications, adverse effects, and alternative therapies for Bromfed DM (brompheniramine/pseudoephedrine/dextromethorphan) cough syrup in patients aged 4 years and older?

Bromfed DM Cough Syrup: Clinical Guide

Composition and Active Ingredients

Bromfed DM contains three active components: brompheniramine (first-generation antihistamine), pseudoephedrine (decongestant), and dextromethorphan (cough suppressant). 1

• Brompheniramine: First-generation antihistamine with anticholinergic properties that provides cough suppression through its anticholinergic effects rather than antihistamine action 1
• Pseudoephedrine: Sympathomimetic decongestant that reduces nasal congestion 1
• Dextromethorphan: Non-sedating centrally-acting antitussive that suppresses the cough reflex 2

---

Evidence-Based Dosing Guidelines

Standard Adult Dosing

For dextromethorphan to achieve meaningful cough suppression, doses of 30-60 mg are required, as standard over-the-counter doses (10-15 mg) are subtherapeutic. 2

• Optimal dextromethorphan dose: 30-60 mg every 6-8 hours (maximum 120 mg/day) for maximal cough reflex suppression 2
• First-generation antihistamine/decongestant combinations: Dexbrompheniramine 6 mg twice daily plus pseudoephedrine 120 mg twice daily have proven efficacy 1
• Bedtime dosing: 15-30 mg dextromethorphan at bedtime helps suppress nocturnal cough and promote sleep 2

Pediatric Considerations (Ages 4+)

• Ages 6-11 years: 15 mg dextromethorphan (approximately 0.45-0.60 mg/kg provides better symptom control than lower doses) 3
• Ages 12-18 years: 30 mg dextromethorphan 3
• Critical pitfall: Age-based dosing results in substantial variability; weight-based dosing of 0.5 mg/kg may optimize efficacy while minimizing adverse events 3

---

Clinical Indications

First-generation antihistamine/decongestant combinations are most effective for non-histamine-mediated upper airway cough syndrome (postnasal drip), postviral cough, and common cold-associated cough. 1

Appropriate Use

• Postviral upper respiratory infection cough: First-generation antihistamine/decongestant combinations work through anticholinergic properties 1
• Common cold with rhinorrhea and nasal congestion: Combination therapy addresses multiple symptoms 1, 4
• Acute dry cough: When simple remedies (honey/lemon) fail and pharmacologic intervention is needed 2
• Nocturnal cough: Sedating antihistamine component particularly useful for sleep disruption 2, 5

When NOT to Use

• Allergic rhinitis: Newer non-sedating antihistamines are more effective; first-generation antihistamines work primarily through anticholinergic effects 1
• Productive cough requiring secretion clearance: Cough suppression contraindicated in pneumonia, bronchiectasis 2
• Asthma or COPD with protective cough function: Treat underlying disease rather than suppress cough 2

---

Absolute Contraindications and Precautions

Decongestant (Pseudoephedrine) Contraindications

Pseudoephedrine poses significant cardiovascular and urologic risks that may necessitate discontinuation. 1

• Severe hypertension or uncontrolled hypertension: Risk of worsening blood pressure 1
• Symptomatic benign prostatic hypertrophy: Worsening urinary retention 1
• Narrow-angle glaucoma: Increased intraocular pressure from both decongestant and anticholinergic effects 1
• Tachycardia, palpitations, or cardiac arrhythmias: Sympathomimetic effects 1

Antihistamine (Brompheniramine) Contraindications

• Narrow-angle glaucoma: Anticholinergic effects increase intraocular pressure 1
• Urinary retention or prostatic hypertrophy: Anticholinergic effects worsen urination difficulty 1
• Concurrent MAO inhibitor use: Risk of hypertensive crisis 1

Dextromethorphan Contraindications

• CYP2D6 poor metabolizers (approximately 5% of European populations): Rapid accumulation to toxic levels 6
• Concurrent MAO inhibitor therapy: Risk of serotonin syndrome 6
• Suspected pneumonia (tachycardia, tachypnea, fever, abnormal chest exam): Must rule out bacterial infection first 2

---

Adverse Effects Profile

Common Side Effects

Sedation from the antihistamine component is the primary adverse effect, though a meta-analysis questions whether first-generation antihistamines cause significantly more sedation than newer agents. 1

• Sedation/drowsiness: Most common with antihistamine component; initiate once daily at bedtime for several days before advancing to twice-daily dosing to minimize this effect 1
• Dry mouth: Anticholinergic effect, reported commonly but rarely leads to discontinuation 1
• Transient dizziness: Reported in controlled trials but rarely severe 1
• Insomnia, jitteriness: From pseudoephedrine component 1

Serious Adverse Effects

• Urinary retention: Particularly in older men with prostatic hypertrophy 1
• Acute angle-closure glaucoma: From anticholinergic and sympathomimetic effects 1
• Hypertensive crisis: Pseudoephedrine in susceptible patients 1
• Psychosis and ataxia: Dextromethorphan/pseudoephedrine combination in overdose or overmedication 7
• Abuse potential: Dextromethorphan megadoses (5-10 times therapeutic dose) produce PCP-like effects; adolescents at particular risk 6

Additive Toxicity Warning

Many combination products contain acetaminophen or other ingredients; higher doses of dextromethorphan (60 mg) may result in toxic levels of these additional components. 2, 6

---

Evidence-Based Alternatives

First-Line Non-Pharmacologic Options

Simple home remedies like honey and lemon should be considered first for benign viral cough, as they may be as effective as pharmacological treatments. 2, 8

• Honey and lemon mixture: Simplest, cheapest first-line treatment with patient-reported benefit 2
• Voluntary cough suppression: Central modulation may sufficiently reduce cough frequency 2

Preferred Pharmacologic Alternative

Dextromethorphan alone (without antihistamine/decongestant) is the preferred antitussive due to superior safety profile compared to combination products or codeine-based alternatives. 2

• Dextromethorphan monotherapy: 30-60 mg every 6-8 hours provides optimal cough suppression without decongestant/antihistamine risks 2
• Non-sedating antihistamine combinations: Bilastine/dextromethorphan/phenylephrine provides non-sedating alternative with significantly lower drowsiness scores 4

When Bromfed DM Components Are Contraindicated

• Ipratropium bromide nasal spray: Effective when first-generation antihistamine/decongestant contraindicated (glaucoma, prostatic hypertrophy) 1
• Inhaled ipratropium: First-line for postinfectious cough before considering central antitussives 2
• Menthol inhalation: Acute, short-lived cough suppression for breakthrough symptoms 2

NOT Recommended Alternatives

Codeine-containing products should be avoided as they provide no greater efficacy than dextromethorphan but have significantly more adverse effects including drowsiness, nausea, constipation, and physical dependence. 2

• Codeine or pholcodine: No efficacy advantage over dextromethorphan with much greater adverse effect profile 2
• Guaifenesin (expectorants): Not indicated for dry cough; functions as expectorant, not suppressant 2
• Promethazine: No established efficacy for cough; associated with serious adverse effects including respiratory depression and extrapyramidal reactions 2

---

Clinical Decision Algorithm

Step 1: Assess Cough Characteristics and Red Flags

• Hemoptysis, breathlessness, tachypnea: Requires immediate medical evaluation, not antitussive therapy 2
• Fever, malaise, purulent sputum: Evaluate for pneumonia or serious lung infection 2
• Cough >3 weeks: Full diagnostic workup required rather than continued symptomatic treatment 2

Step 2: Identify Contraindications

• Screen for: Hypertension, glaucoma, prostatic hypertrophy, cardiac arrhythmias, MAO inhibitor use 1
• If contraindications present: Use dextromethorphan alone or ipratropium bromide 1, 2

Step 3: Select Appropriate Therapy

For postviral cough or common cold with rhinorrhea/congestion in patients without contraindications:

• Bromfed DM (or equivalent first-generation antihistamine/decongestant/dextromethorphan combination) is appropriate 1
• Initiate once daily at bedtime to minimize sedation, advance to twice daily after several days 1
• Ensure dextromethorphan component is at least 30 mg per dose for adequate suppression 2

For isolated dry cough without nasal symptoms:

• Dextromethorphan alone 30-60 mg every 6-8 hours is preferred to avoid unnecessary decongestant/antihistamine exposure 2

For nocturnal cough disrupting sleep:

• First-generation sedating antihistamine component provides dual benefit of cough suppression and sleep promotion 2, 5

Step 4: Monitor Response and Duration

• Expected improvement: Within days to 2 weeks of initiation 1
• If no improvement after short course: Discontinue and reassess for alternative diagnoses 2
• Maximum duration: Acute cough therapy should not extend beyond 3 weeks without diagnostic workup 2

---

Critical Prescribing Pitfalls to Avoid

1. Using subtherapeutic dextromethorphan doses (<30 mg): Standard OTC doses often inadequate for meaningful suppression 2

2. Overlooking combination product ingredients: Risk of acetaminophen toxicity or additive effects when using higher dextromethorphan doses 2, 6

3. Prescribing to patients with unrecognized contraindications: Particularly glaucoma, prostatic hypertrophy, uncontrolled hypertension 1

4. Suppressing productive cough: When secretion clearance is beneficial (pneumonia, bronchiectasis), cough suppression is harmful 2

5. Continuing therapy beyond 2-3 weeks: Persistent cough requires diagnostic evaluation, not prolonged symptomatic treatment 2

6. Using in adolescents without abuse risk counseling: Dextromethorphan has significant abuse potential in this population 6